A further aspect of the present invention relates to {HEAD ~ a pharmaceutical or diagnostic composition} comprising as an active agent {TAIL ~ at least one fusion protein}, one respective nucleic acid encoding therefor, one transformed or transfected cell as well as one trimeric complexe or oligomer of the trimeric complexes, all as described herein 
comprising
A further aspect of the present invention relates to { HEAD ~ a pharmaceutical or diagnostic composition } comprising as an active agent { TAIL ~ at least one fusion protein } , one respective nucleic acid encoding therefor , one transformed or transfected cell as well as one trimeric complexe or oligomer of the trimeric complexes , all as described herein
OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH